Cannabis Report
Home > Boards > US OTC > Biotechs >

ProMIS Neurosciences Inc. (ARFXF)

ARFXF RSS Feed
Add ARFXF Price Alert      Hide Sticky   Hide Intro
Moderator: noretreat, Matagordaville
Search This Board: 
Last Post: 7/14/2018 12:07:38 PM - Followers: 22 - Board type: Free - Posts Today: 0

ProMIS Neurosciences
ProMIS Neurosciences Inc.
1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2
Canada
416-847-6898
http://www.promisneurosciences.com

ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops therapeutics and diagnostics for the treatment of neurodegenerative diseases in Canada. It develops technology for treatment of Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's disease (AD). The company has strategic alliances with Epitomics Inc. to develop murine monoclonal antibodies; and license agreement with Biogen Idec for developing therapeutics to treat ALS. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences Inc. in July 2015. ProMIS Neurosciences Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
 
 
Harnessing the power of precision medicine to conquer Alzheimer's disease



Corporate Overview January 23, 2018 updated in March
https://promisneurosciences.com/2016site/wp-content/uploads/2018/03/ProMIS-Corp-OV_final_March-2018-.pdf


Video Presentations:

Eugene Williams, Executive Chairman presents at Noble Capital Markets' Fourteenth Annual Investors Conference
https://promisneurosciences.com/presentations/eugene-williams-executive-chairman-presents-noble-capital-markets-fourteenth-annual-investor-conference/


Dr. Elliot Goldstein, President and CEO presents at Cantech Investment Conference January 31, 2018
https://www.youtube.com/watch?v=TglpDeE1xZ4


Poster:
Achieving the optimal profile for Alzheimer's immunotherapy: Rational generation of antibodies specific for toxic AB oligomers
https://promisneurosciences.com/2016site/wp-content/uploads/2017/04/April-17-Final-Plotkin-AAN_Poster-3-1.pdf

Cannabis Report
ARFXF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARFXF News: Small Company Offering and Sale of Securities Without Registration (d) 05/03/2018 03:51:42 PM
ARFXF News: Amorfix announces fiscal 2014 year end results 06/13/2014 06:00:00 PM
ARFXF News: William Wyman appointed Amorfix Chairman of the Board 06/12/2014 07:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#222  Sticky Note Video Presentations: ARFXF Alzheimers Matagordaville 07/13/18 09:06:28 AM
#151  Sticky Note 2-page fact sheet noretreat 02/14/18 08:10:12 AM
#226   Furthermore some press releases from the company could Matagordaville 07/14/18 12:07:38 PM
#225   Tom initially NR I believe found this in Matagordaville 07/14/18 10:32:38 AM
#224   Love this stock and opportunity but there is pennymonster1 07/14/18 07:55:51 AM
#223   M-ville,thanks for the heads up on this one. 123tom 07/14/18 05:31:53 AM
#222   Video Presentations: ARFXF Alzheimers Matagordaville 07/13/18 09:06:28 AM
#221   ProMIS Neurosciences to Present Preclinical Data on Alzheimer's noretreat 07/10/18 08:31:20 AM
#220   Biogen news should give this a push. noretreat 07/08/18 07:35:29 PM
#219   Trending up ...BIIB positive Alzheimer’s news helping here perhaps Matagordaville 07/06/18 01:21:57 PM
#218   Thanks. Similar to other publicity. I’m slowly building noretreat 06/21/18 08:15:06 PM
#217   https://www.clinicalleader.com/doc/promis-trial-offers-hope-for-alzheimer-s-pati Matagordaville 06/21/18 04:22:12 PM
#216   ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead noretreat 06/12/18 07:38:09 AM
#215   back in with a small position (25k) today. noretreat 06/04/18 03:49:56 PM
#214   Tmxmoney.com Moneyonme123 05/23/18 10:41:07 AM
#213   and you know this how? pennymonster1 05/22/18 08:47:23 PM
#212   Scotia capital is on a buying spree today Moneyonme123 05/22/18 10:42:15 AM
#211   Not even sure if this is a valid Amatuer17 05/21/18 08:22:30 PM
#210   This one is drifting lower slowly. Matagordaville 05/21/18 04:54:15 PM
#209   .28 on the bid Matagordaville 05/21/18 12:16:45 PM
#208   .295. Time to renew interest in this one. noretreat 05/19/18 03:44:09 PM
#205   In the 20's I will start buying again. noretreat 05/01/18 12:37:27 PM
#204   Good news on the funding front...IND coming eventually noretreat 05/01/18 12:32:14 PM
#203   PROMIS NEUROSCIENCES CLOSES $7.2 MILLION PRIVATE PLACEMENT TORONTO, Ontario Matagordaville 05/01/18 10:55:29 AM
#202   ProMIS Neurosciences Announces Appointment of Ernest Bush as Matagordaville 04/03/18 10:33:38 AM
#201   What’s with the volume today Matagordaville 03/28/18 03:18:35 PM
#200   See the presentation ProMIS Neurosciences (ARFXF) Presents At The Amatuer17 03/26/18 06:42:19 PM
#199   that is the million dollar question. seems noretreat 03/23/18 04:34:09 PM
#198   The space is good - the technology in Amatuer17 03/23/18 03:49:55 PM
#197   Is this priced right at the o/s count Matagordaville 03/23/18 01:42:58 PM
#196   70,000 on the bid .3603 Matagordaville 03/23/18 01:24:06 PM
#195   Buy out is what I meant..... noretreat 03/20/18 05:44:17 PM
#194   A bout out is what I am hoping noretreat 03/20/18 05:29:40 PM
#193   When’s the raise? Matagordaville 03/20/18 04:01:37 PM
#192   I think they'll license their platform out to runncoach 03/19/18 09:59:17 PM
#191   And people with a great track record sometimes noretreat 03/19/18 07:34:34 PM
#190   They are taking same path as AXON and Amatuer17 03/19/18 08:17:31 AM
#189   But the start is 9 plus months away Amatuer17 03/19/18 08:14:55 AM
#188   Alzheon files for $80M IPO to take once-failed Matagordaville 03/19/18 07:57:59 AM
#187   I hope - ARTH also had qualified people Amatuer17 03/16/18 05:33:07 PM
#186   Exactly and they are pursuing a path that runncoach 03/16/18 04:58:25 PM
#185   They have a no bullshit board noretreat 03/16/18 04:54:16 PM
#184   Volume up today? Matagordaville 03/16/18 10:25:56 AM
#183   CEO is very smooth in delivery - reminds Amatuer17 03/16/18 08:49:25 AM
#182   They will do a 10:1 r/s so the Amatuer17 03/16/18 08:35:48 AM
#181   No chance! noretreat 03/14/18 10:04:51 PM
#180   Maybe some Aspire funding? Ha! scottsmith 03/14/18 01:03:46 PM
#179   http://bit.ly/2FxBuUv Narrated Overview Matagordaville 03/14/18 12:42:11 PM
#178   Fiscal year results out today. Expenses going up noretreat 03/14/18 09:52:46 AM
#177   ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results Mar Matagordaville 03/14/18 09:32:13 AM
#176   The Company’s top priority for 2018 is to Amatuer17 03/14/18 09:07:13 AM
#175   Efficacy shown in Phase 1.....could be big. Matagordaville 03/13/18 10:06:44 PM
PostSubject